The 2023 recommendations of the European Society of Human Reproduction and Embryology (ESHRE) suggest that serum anti-Müllerian hormone (AMH) levels could serve as an alternative to ultrasound examination in diagnosing PCOS [1]. Here, AMH is linked to polycystic ovary syndrome.